ALNT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ALNT is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 who is impatient and wants to act now. The stock has solid operational momentum and bullish analyst sentiment, but the current price is already near resistance and the short-term technical setup looks stretched. Best direct call: hold and wait for a better entry rather than buying immediately.
ALNT is in a bullish trend overall. The moving averages are aligned positively (SMA_5 > SMA_20 > SMA_200), and MACD is above zero with a positive expanding histogram, which supports upward momentum. However, RSI_6 is 71.674, suggesting the stock is extended in the near term. Price at 77.67 is above the pivot of 73.657 and close to resistance at R1 76.426 and R2 78.136, so upside from here looks limited in the short run. The recent pattern data also points to weak near-term follow-through, with a projected -0.91% next day move and only slight weekly gain expectation.
Financial results for 2025/Q4 were strong, with revenue up 17.49% YoY, net income up 111.85% YoY, EPS up 111.11% YoY, and gross margin up to 30.2%. The company also has an earnings date upcoming on 2026-05-06, which may act as a catalyst if results beat expectations.
No fresh news was reported in the last week, so there is no near-term event-driven boost from headlines. Insider activity is a negative signal: insiders are selling, and the selling amount increased 703.25% over the last month. Hedge funds are neutral with no significant trading trends over the last quarter. The stock is also trading near resistance after a sharp move higher, which reduces immediate entry attractiveness.
In Q4 2025, Allient showed strong growth and improving profitability. Revenue reached $143.354M, up 17.49% YoY, net income rose to $6.383M, up 111.85% YoY, EPS increased to $0.38, up 111.11% YoY, and gross margin improved to 30.2%, up 4.50% YoY. This is a strong latest-quarter season, indicating healthy growth trends and margin expansion.
Analyst sentiment is clearly positive. Roth Capital upgraded its price target to $69 from $56 and maintained a Buy rating, while Lake Street initiated coverage with a Buy rating and $79 target. The Wall Street pros view is constructive on ALNT, emphasizing improving margins, cash generation, revenue acceleration, and secular tailwinds. The main con is that the current market price is already above Roth's target and approaching Lake Street's target, which limits near-term upside from here.
